Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „subjects“
Suchtreffer
Begriffe & Kennungen
Abilify Maintena · 4.5 · 7 Quinidine and other strong CYP2D6 inhibitors In a clinical trial of oral aripiprazole in healthy subjects, a
Eintrag öffnenAbilify Maintena · 4.5 · Ketoconazole and other strong CYP3A4 inhibitors In a clinical trial of oral aripiprazole in healthy subjects,
Eintrag öffnenAbilify Maintena · 4.5 · Ketoconazole and other strong CYP3A4 inhibitors In a clinical trial of oral aripiprazole in healthy subjects,
Eintrag öffnenAbilify Maintena · 4.5 · Quinidine and other strong CYP2D6 inhibitors In a clinical trial of oral aripiprazole in healthy subjects, a s
Eintrag öffnenAbiraterone Mylan · 4.5 · In a CYP2C8 drug-drug interaction study in healthy subjects, the AUC of pioglitazone was increased by 46% and
Eintrag öffnenAbiraterone Mylan · 4.5 · In a separate clinical pharmacokinetic interaction study of healthy subjects, co-administration of ketoconazol
Eintrag öffnenAbseamed · 4.8 · Of a total 3 417 subjects in 25 randomised, double-blinded, placebo or standard of care controlled studies, th
Eintrag öffnenAdenuric · 4.5 · Theophylline An interaction study in healthy subjects has been performed with febuxostat to evaluate whether t
Eintrag öffnenAdenuric · 4.5 · Theophylline An interaction study in healthy subjects has been performed with febuxostat to evaluate whether t
Eintrag öffnenAdenuric · 4.8 · Summary of the safety profile The most commonly reported adverse reactions in clinical trials (4,072 subjects
Eintrag öffnenAdenuric · 4.8 · Summary of the safety profile The most commonly reported adverse reactions in clinical trials (4,072 subjects
Eintrag öffnenAdtralza · 4.8 · Eczema herpeticum Eczema herpeticum was reported in 0.3% of the subjects treated with tralokinumab and in 1.5%
Eintrag öffnenAdtralza · 4.8 · Keratitis was reported in 0.5% of subjects treated with tralokinumab during the initial treatment period. Of t
Eintrag öffnenAdvate · 4.8 · Clinical studies with ADVATE included 418 subjects with at least one exposure to ADVATE reporting in total 93
Eintrag öffnenAdvate · 4.8 · Clinical studies with ADVATE included 418 subjects with at least one exposure to ADVATE reporting in total 93
Eintrag öffnenAdynovi · 4.8 · None of the subjects who participated in one or more of 6 completed clinical trials in PTPs developed persiste
Eintrag öffnenAdynovi · 4.8 · None of the subjects who participated in one or more of 6 completed clinical trials in PTPs developed persiste
Eintrag öffnenAkeega · 4.5 · CYP2C8 substrates Abiraterone is an inhibitor of CYP2C8. In a clinical study in healthy subjects, the AUC of p
Eintrag öffnenAkeega · 4.5 · In a separate clinical study in healthy subjects, co-administration of ketoconazole, a strong inhibitor of CYP
Eintrag öffnenAlli (previously Orlistat GSK) · 4.5 · The vast majority of subjects receiving up to 4 full years of treatment with orlistat in clinical studies had
Eintrag öffnen